Endocarditis 2014: An update

Heart and Lung: Journal of Acute and Critical Care

Volumn 43, Issue 4, 2014, Pages 334-337

  Thanavaro, Kristin L ^a   Nixon, J V ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiac device infections; Cardiac valve disease; Endocarditis

Indexed keywords

AMPICILLIN; CEFTRIAXONE; DAPTOMYCIN; GENTAMICIN; PENICILLIN DERIVATIVE; RIFAMPICIN; VANCOMYCIN;

ANTIBIOTIC THERAPY; BACTERIAL ENDOCARDITIS; CARDIOVASCULAR MORTALITY; CONGENITAL HEART DISEASE; DEVICE INFECTION; DEVICE REMOVAL; DISEASE PREDISPOSITION; ENDOCARDITIS; EVIDENCE BASED PRACTICE; FUNGAL ENDOCARDITIS; HEART GRAFT; HEART TRANSPLANTATION; HEART VALVE PROSTHESIS; HUMAN; INDWELLING CATHETER; MORBIDITY; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; SINUS NODE; TREATMENT DURATION; VALVULAR HEART DISEASE;

CARDIAC DEVICE INFECTIONS; CARDIAC VALVE DISEASE; ENDOCARDITIS;

ANTI-BACTERIAL AGENTS; ENDOCARDITIS; HEART DEFECTS, CONGENITAL; HEART TRANSPLANTATION; HEART VALVE DISEASES; HUMANS; PRACTICE GUIDELINES AS TOPIC; PROSTHESIS-RELATED INFECTIONS;

EID: 84903530001     PISSN: 01479563     EISSN: 15273288     Source Type: Journal    
DOI: 10.1016/j.hrtlng.2014.03.009     Document Type: Review

References (26)

1. Wilson W., Taubert K.A., Gewitz M., et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council of Clinical Cardiology, Council on Cardiovascular Surgery, and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2007, 116:1736-1754.
2. Baddour L.M., Epstein A.E., Erickson C.C., et al. Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation 2010, 121:458-477. on behalf of the American Heart Association's Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, Council on Cardiovascular Surgery and Anesthesia, Council on Cardiovascular Nursing, Council on Clinical Cardiology, and the Interdisciplinary Council on Quality of Care and Outcomes Research.
3. Baddour L.M., Wilson W.R., Bayer A.S., et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 2005, 111:e394-e434.
4. Li J.S., Sexton D.J., Mick N., et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000, 30:633-638.
5. Dajani A.S., Taubert K.A., Wilson W., et al. Prevention of bacterial endocarditis: recommendations by the American Heart Association. JAm Med Assoc 1997, 277:1794-1801.
6. Diekema D.J., Beach M.L., Pfaller M.A., Jones R.N. Antimicrobial resistance in viridans group streptococci among patients with and without the diagnosis of cancer in the USA, Canada and Latin America. Clin Microbiol Infect 2001, 7:152-157. SENTRY Participants Group.
7. Groppo F.C., Castro F.M., Pacheco A.B., et al. Antimicrobial resistance of Staphylococcus aureus and oral streptococci strains from high-risk endocarditis patients. Gen Dent 2005, 53:410-413.
8. Teng L.J., Hsueh P.R., Chen Y.C., Ho S.W., Luh K.T. Antimicrobial susceptibility of viridans group streptococci in Taiwan with an emphasis on the high rates of resistance to penicillin and macrolides in streptococcus oralis. JAntimicrob Chemother 1998, 41:621-627.
9. Tuohy M., Washington J.A. Antimicrobial susceptibility of viridans group streptococci. Diagn Microbiol Infect Dis 1997, 29:277-280.
10. Prabhu R.M., Piper K.E., Baddour L.M., Steckelberg J.M., Wilson W.R., Patel R. Antimicrobial susceptibility patterns among viridans group streptococcal isolates from infective endocarditis patients from 1971 to 1986 and 1994 to 2002. Antimicrob Agents Chemother 2004, 48:4463-4465.
11. Strom B.L., Abrutyn E., Berlin J.A., et al. Dental and cardiac risk factors for infective endocarditis: a population-based, case control study. Ann Intern Med 1998, 129:761-769.
12. Schwartz I.S., Pervez N. Bacterial endocarditis associated with a permanent transvenous cardiac pacemaker. JAm Med Assoc 1971, 218:736-737.
13. Conklin E.F., Giannelli S., Nealon T.F. Four hundred consecutive patients with permanent transvenous pacemakers. JThorac Cardiovasc Surg 1975, 69:1-7.
14. Bluhm G. Pacemaker infections: a clinical study with special reference to prophylactic use of some isoxazolyl penicillins. Acta Med Scand Suppl 1985, 699:1-62.
15. Zhan C., Baine W.B., Sedrakyan A., Steiner C. Cardiac device implantation in the United States from 1997 through 2004: a population-based analysis. JGen Intern Med 2008, 23(suppl 1):13-19.
16. Baddour L.M., Bettmann M.A., Bolger A.F., et al. Nonvalvular, cardiovascular device-related infections. Circulation 2003, 108:2015-2031.
17. Uslan D.Z., Sohail M.R., St Sauver J.L., et al. Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study. Arch Intern Med 2007, 167:669-675.
18. Voigt A., Shalaby A., Saba S. Rising rates of cardiac rhythm management device infections in the United States: 1996 through 2003. JAm Coll Cardiol 2006, 48:590-591.
19. Sohail M.R., Uslan D.Z., Khan A.H., et al. Management and outcome of permanent and implantable cardioverter-defibrillator infections. JAm Coll Cardiol 2007, 49:1851-1859.
20. Wilkoff B.L., Love C.J., Byrd C.L., et al. Transvenous lead extraction: Heart Rhythm Society expert consensus on facilities, training, indications and patient management: endorsed by the American Heart Association. Heart Rhythm 2009, 6:1085-1104.
21. Doulton T., Sabharwal N., Cairns H.S., et al. Infective endocarditis in dialysis patients: new challenges and old. Kidney Int 2003, 64:720-727.
22. Jones D.A., McGill L.A., Rathod K.S., et al. Characteristics and outcomes of dialysis patients with infective endocarditis. Nephron Clin Pract 2013, 123:151-156.
23. Rekik S., Trabelsi I., Hentati M., et al. Infective endocarditis in hemodialysis patients: clinical features, echocardiographic data and outcome. Clin Exp Nephrol 2009, 13:350-354.
24. Hickson L.J., Gooden J.Y., Le K.Y., et al. Clinical presentation and outcomes of cardiovascular implantable electronic device infections in hemodialysis patients. Am J Kidney Dis 2014, article in press and published online. http://dx.doi.org/10.1053/j.ajkd.2013.11.018.
25. Nienaber J., Wilhelm M.P., Sohali M.Z. Current concepts in the diagnosis and management of left ventricular assist device infections. Exp Rev Anti Infect Ther 2013, 11(2):201-210.
26. Nienaber J., Kusne S., Riaz T., et al. Clinical manifestations and management of left ventricular assist device-associated infections. Clin Infect Dis 2013, 3(57):1438-1448.